COMPANY PROFILE / #989
Elephas
Developer of live tumor diagnostic technology designed to assess patient response to immunotherapy from core needle biopsy samples before treatment initiation. The company offers a platform that integrates cancer biology, multimodal microscopy, engineering, artificial intelligence, and analysis of live human tumor fragments, enabling clinicians to inform treatment decisions for cancer patients and support drug development efforts.Privately Held (backing)
已融资125
最新估值—
员工数—
成立年份Veracyte, Biodesix, Insight Molecular Diagnostics
公司概况
- Companies
- Elephas
- Description
- —
- Website
- Madison, WI
- HQ Location
- Developer of live tumor diagnostic technology designed to assess patient response to immunotherapy from core needle biopsy samples before treatment initiation. The company offers a platform that integrates cancer biology, multimodal microscopy, engineering, artificial intelligence, and analysis of live human tumor fragments, enabling clinicians to inform treatment decisions for cancer patients and support drug development efforts.
- Year Founded
- Veracyte, Biodesix, Insight Molecular Diagnostics
- Keywords
- 2026: 125, 2025: 100, 2024: 141, 2023: 107, 2022: 79, 2021: 57, 2020: 14
- Competitors
- —
- Ownership Status
- —
- Company Financing Status
- Privately Held (backing)
融资与估值
- Total Raised
- 125
- First Financing Date
- 31.00
- First Financing Size
- 96
- First Financing Valuation
- vjergens@elephas.com
- Last Financing Date
- 0.72%
- Last Financing Deal Type
- 06-Nov-2025
- Last Financing Size
- Later Stage VC
- Last Financing Valuation
- —
- Last Financing Status
- 281.00
- Last Known Valuation
- —
- Last Known Valuation Date
- Later Stage VC
- Last Known Valuation Deal Type
- 7.00
- Valuation Estimate
- 06-Nov-2025
- Valuation Estimate Growth Rate
- artificial intelligence, cancer biology, diagnostic imaging, drugs biotech, health care, imaging diagnostics, life sciences industry, medical device, precision medicine, tumor diagnostic
- Active Investors
- Venture Capital-Backed
- # Active Investors
- 7%
- Acquirers
- ARCH Venture Partners, Clarevia Ventures, Moore Capital Management, Moore Strategic Ventures, Northpond Ventures, Sands Capital, State of Wisconsin Investment Board, Tao Capital Partners, WARF Ventures
团队与联系人
- Employees
- —
- Employee Growth %
- 2020
- Employee History
- —
- Primary Contact
- 169.20
- Primary Contact Title
- +1 515 297 3004
- Primary Contact Email
- Victor Jergens
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- 53.45%
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- 143
- Size Multiple
- —
- Size Multiple % Change
- 281.00
- Size Multiple Change
- 0.00%
- Size Multiple Percentile
- 0.00x
- Majestic Referring Domains
- 15.63x
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- 15-May-2021
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- 847
- Success Probability Over Time – 1 Year
- 19%
- Success Probability Over Time – 3 Year
- 30%
- Success Probability Over Time – 5 Year
- Senior Business Analyst
记录来源：public.companies · 原始序号 #989 · 所有字段均按数据库原值展示。